- Home
- KMDA vs MYN Comparison
KMDA vs MYN Comparison
Compare KMDA & MYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- MYN
- Stock Information
- Founded
- KMDA 1990
- MYN 1992
- Country
- KMDA Israel
- MYN United States
- Employees
- KMDA N/A
- MYN N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- MYN Finance Companies
- Sector
- KMDA Health Care
- MYN Finance
- Exchange
- KMDA Nasdaq
- MYN Nasdaq
- Market Cap
- KMDA 394.4M
- MYN 411.5M
- IPO Year
- KMDA N/A
- MYN N/A
- Fundamental
- Price
- KMDA $6.92
- MYN $10.18
- Analyst Decision
- KMDA Strong Buy
- MYN
- Analyst Count
- KMDA 2
- MYN 0
- Target Price
- KMDA $14.50
- MYN N/A
- AVG Volume (30 Days)
- KMDA 159.8K
- MYN 86.0K
- Earning Date
- KMDA 03-05-2025
- MYN 01-01-0001
- Dividend Yield
- KMDA N/A
- MYN 4.12%
- EPS Growth
- KMDA 124.29
- MYN N/A
- EPS
- KMDA 0.27
- MYN N/A
- Revenue
- KMDA $158,380,000.00
- MYN N/A
- Revenue This Year
- KMDA $15.37
- MYN N/A
- Revenue Next Year
- KMDA $8.58
- MYN N/A
- P/E Ratio
- KMDA $25.36
- MYN N/A
- Revenue Growth
- KMDA 4.52
- MYN N/A
- 52 Week Low
- KMDA $4.74
- MYN $8.47
- 52 Week High
- KMDA $8.00
- MYN $10.62
- Technical
- Relative Strength Index (RSI)
- KMDA 50.80
- MYN 50.91
- Support Level
- KMDA $6.90
- MYN $10.04
- Resistance Level
- KMDA $7.56
- MYN $10.18
- Average True Range (ATR)
- KMDA 0.19
- MYN 0.09
- MACD
- KMDA -0.09
- MYN 0.01
- Stochastic Oscillator
- KMDA 15.95
- MYN 51.61
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock
Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests primarily in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.